Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Scott Patterson to Present at GTC’s 7th Oncology Biomarkers Mtg on March 19-21, 2014 in San Diego - Scott Patterson, Executive Director of Medical Sciences at Amgen to Give a Featured Presentation on “Continued Exploration of Tumor Molecular Characteristics Further Improves Patient Outcomes” at the 7th Oncology Biomarkers Conference
Scott Patterson to Present at GTC’s 7th Oncology Biomarkers Mtg on March 19-21, 2014 in San Diego

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2013/11/24 - Scott Patterson, Executive Director of Medical Sciences at Amgen to Give a Featured Presentation on “Continued Exploration of Tumor Molecular Characteristics Further Improves Patient Outcomes” at the 7th Oncology Biomarkers Conference.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Scott Patterson, Executive Director of Medical Sciences at Amgen will give a featured presentation on “Continued Exploration of Tumor Molecular Characteristics Further Improves Patient Outcomes” at the 7th Oncology Biomarkers Conference (March 19-21, 2014 in San Diego, CA)

In his presentation Dr. Patterson will describe how the development of targeted therapeutics for global populations requires identification of that segment of the patient population that displays the greatest benefit:risk profile, enabling demonstration of the value of the therapeutic to patients and associated stakeholders. When expression level variation or mutation status of the therapeutic target does not confer predictive value, examination of downstream pathway elements may prove valuable. Such is the case for therapeutic antibodies directed against the EGF receptor. Since confirmation of the negative predictive value of the most common somatic mutations in KRAS exon 2, studies have been undertaken to determine if additional biomarkers can be employed to further define the patient population most likely to benefit from this therapeutic approach. Dr. Patterson will describe the strategy of hypothesis generation and testing and the methods employed over the past seven years.

The 7th Oncology Biomarkers Conference brings together experts from industry and academia to discuss the latest developments in the biomarkers and diagnostics arena specifically to the field of oncology. This conference is part of the larger Biomarker Summit 2014 which includes the following co-located conferences:

1) 3rd Neurological Biomarkers
2) 3rd Inflammatory & Immunological Biomarkers

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Scott Patterson to Present at GTC’s 7th Oncology Biomarkers Mtg on March 19-21, 2014 in San Diego

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today